CG
BEAT

Cutler Group’s BioTelemetry, Inc. BEAT Stock Holding History

Cutler Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,600
Closed -$74K – 5056
2019
Q4 		$74K Hold
1,600
– – ﹤0.01% 1373
2019
Q3 		$65K Hold
1,600
– – 0.01% 1357
2019
Q2 		$77K Buy
+1,600
New +$84.1K 0.01% 1252
2018
Q2 		– Sell
-400
Closed -$15.9K – 5361
2018
Q1 		$12K Buy
400
+200
+100% +$6.58K ﹤0.01% 2704
2017
Q4 		$5K Sell
200
-1,494
-88% -$43.3K ﹤0.01% 3733
2017
Q3 		$55K Sell
1,694
-11,042
-87% -$382K ﹤0.01% 2166
2017
Q2 		$426K Buy
+12,736
New +$380K 0.02% 789
2017
Q1 		– Sell
-17,523
Closed -$434K – 7905
2016
Q4 		$391K Buy
17,523
+8,972
+105% +$175K 0.01% 843
2016
Q3 		$158K Buy
8,551
+5,989
+234% +$113K 0.01% 1425
2016
Q2 		$41K Buy
2,562
+2,050
+400% +$30.2K ﹤0.01% 2576
2016
Q1 		$5K Buy
+512
New +$5.72K ﹤0.01% 4969

Other funds holding BEAT

LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Cutler Group's BEAT Position: Q1 2020 in Review

Cutler Group sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 1,600 shares — an estimated $74K sold.

Cutler Group first reported a position in BEAT in Q1 2016 and held it in 11 quarters. The position peaked at $426K in Q2 2017. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

  • Cutler Group reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 1,600 BioTelemetry, Inc. shares in Q1 2020, an estimated $74K.
  • Cutler Group first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 11 quarters.
  • Cutler Group's BioTelemetry, Inc. position peaked at $426K in Q2 2017.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.